Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates


Follow the latest updates of the coronavirus (Covid-19) outbreak on our timeline

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Jack Ma Foundation has awarded a $2.1m grant to four research teams at Columbia University to identify antiviral drugs and antibodies that can be used against the Covid-19 coronavirus.

The grant will be split between the four teams, which will partner with academic researchers in China trying to control the spread of the coronavirus epidemic.

Teams from Columbia will explore four different methods to develop drugs and antibodies that can stop viral replication.

Each of the different approaches will be based on previous knowledge from the successes of antiviral therapies formulated against HIV and hepatitis C.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Columbia teams will pursue projects aimed at identifying or developing two types of antiviral drugs and one type of virus-neutralizing antibody

The teams will aim to develop one type of virus-neutralizing antibody and two types of antiviral drugs.

Pharmaceutical Technology Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Pharmaceutical Technology Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving pharmaceutical advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now